BMO ARK Innovation Fund (NEO:ARKK)
Assets | 27.21M |
Expense Ratio | 0.98% |
PE Ratio | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +22.42% |
Volume | 14,068 |
Open | 21.12 |
Previous Close | 20.99 |
Day's Range | 20.96 - 21.50 |
52-Week Low | 15.92 |
52-Week High | 28.27 |
Beta | n/a |
Holdings | 36 |
Inception Date | Nov 14, 2022 |
About ARKK
BMO ARK Innovation Fund is an exchange traded fund launched BMO Investments Inc. The fund is managed by ARK Investment Management LLC. The fund invests in public equity markets of global region. It invests in stocks of companies operating across disruptive innovation involved in the development of technologically enabled products or services associated with fintech innovation, genomic innovation, industrial innovation and next generation internet innovation sectors. It invests in growth and value stocks of companies across diversified market capitalization. It employs fundamental analysis to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the MSCI ACWI Index (C$). BMO ARK Innovation Fund was formed on November 1, 2022 and is domiciled in Canada.
Performance
ARKK had a total return of 22.42% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.30%.
Top 10 Holdings
66.10% of assetsName | Symbol | Weight |
---|---|---|
Tesla, Inc. | TSLA | 11.45% |
Robinhood Markets, Inc. | HOOD | 8.71% |
Palantir Technologies Inc. | PLTR | 8.08% |
Coinbase Global, Inc. | COIN | 7.38% |
Roku, Inc. | ROKU | 7.28% |
Roblox Corporation | RBLX | 6.98% |
CRISPR Therapeutics AG | CRSP | 4.93% |
Tempus AI, Inc. | TEM | 4.58% |
Shopify Inc. | SHOP | 4.32% |
Twist Bioscience Corporation | TWST | 2.39% |